Christopher Dye | |
|---|---|
 | |
| Born | 15 April 1956 |
| Citizenship | British, Irish, French |
| Alma mater | University of York University of Oxford |
| Awards | Fellow of the Royal Society [1] |
| Scientific career | |
| Fields | Epidemiology Public Health |
Christopher Dye FRS, [1] FMedSci (born 15 April 1956) is a biologist, epidemiologist and public health specialist. He is Emeritus Professor of Epidemiology at the University of Oxford and formerly Director of Strategy at the World Health Organization.
Chris Dye trained as a biologist and ecologist (BA University of York) but postgraduate research on mosquitoes (DPhil University of Oxford) led towards epidemiology and public health. Based at Imperial College and the London School of Hygiene and Tropical Medicine from 1982–96, he studied bloodsucking insects as vectors of leishmaniasis, malaria and onchocerciasis in Africa, Asia and South America, and domestic and wild animals as reservoirs of human infection and disease.
Joining the World Health Organization in 1996, he developed ways of analyzing the vast quantities of routine surveillance data (big data) collected by government health departments worldwide ─ extracting signal from noise to devise better methods for understanding and controlling tuberculosis, malaria, and Ebola and Zika viruses. From 2006-09, he was also Gresham Professor of Physic (and other biological sciences), 35th in a lineage of professors that have given public lectures in the City of London since 1597.
As WHO Director of Strategy 2014-18, he served as science advisor to the Director General, oversaw the production and dissemination of health information by WHO press and libraries, and coordinated WHO’s work on health and the Sustainable Development Goals. He is currently Emeritus Professor of Epidemiology at the University of Oxford, where his research focuses on how choices and decisions are made for public and personal health. He has been Epidemiology Advisor to the Chinese Center for Disease Control and Prevention (as 戴诗磊), Gresham Professor of Physic, a member (trustee) of Council of The Royal Society and the University of York, a Visiting Fellow of All Souls College, Oxford and the Oxford Martin School, and a long-time member of the Board of Reviewing Editors for the journal Science.
Dye is a Fellow of The Royal Society, [2] the Royal Society of Biology [3] and the UK Academy of Medical Sciences. [4]
Further articles are listed by PubMed [7] and Google Scholar. [8] Science discussions and lectures have been broadcast by the BBC, Gresham College, YouTube, the British Academy, The Royal Society, the American Association for the Advancement of Science and the National Academy of Medicine.
A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human vertebrate to a human. When humans infect non-humans, it is called reverse zoonosis or anthroponosis.
An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.
Zika fever, also known as Zika virus disease or simply Zika, is an infectious disease caused by the Zika virus. Most cases have no symptoms, but when present they are usually mild and can resemble dengue fever. Symptoms may include fever, red eyes, joint pain, headache, and a maculopapular rash. Symptoms generally last less than seven days. It has not caused any reported deaths during the initial infection. Mother-to-child transmission during pregnancy can cause microcephaly and other brain malformations in some babies. Infections in adults have been linked to Guillain–Barré syndrome (GBS).
Zika virus is a member of the virus family Flaviviridae. It is spread by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. Its name comes from the Ziika Forest of Uganda, where the virus was first isolated in 1947. Zika virus shares a genus with the dengue, yellow fever, Japanese encephalitis, and West Nile viruses. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. From 2007 to 2016, the virus spread eastward, across the Pacific Ocean to the Americas, leading to the 2015–2016 Zika virus epidemic.
Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Ebola vaccines are vaccines either approved or in development to prevent Ebola. As of 2022, there are only vaccines against the Zaire ebolavirus. The first vaccine to be approved in the United States was rVSV-ZEBOV in December 2019. It had been used extensively in the Kivu Ebola epidemic under a compassionate use protocol. During the early 21st century, several vaccine candidates displayed efficacy to protect nonhuman primates against lethal infection.
Galidesivir is an antiviral drug, an adenosine analog. It was developed by BioCryst Pharmaceuticals with funding from NIAID, originally intended as a treatment for hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease, as well as Zika virus. Currently, galidesivir is under phase 1 human trial in Brazil for coronavirus.
Post-Ebola virus syndrome is a post-viral syndrome affecting those who have recovered from infection with Ebola. Symptoms include joint and muscle pain, eye problems, including blindness, various neurological problems, and other ailments, sometimes so severe that the person is unable to work. Although similar symptoms had been reported following previous outbreaks in the last 20 years, health professionals began using the term in 2014 when referring to a constellation of symptoms seen in people who had recovered from an acute attack of Ebola disease.
Alison P. Galvani is an American epidemiologist. She is the Burnett and Stender Families Professor of Epidemiology at the Yale School of Public Health and the Director of the Center for Infectious Disease Modeling and Analysis.
This article primarily covers the chronology of the 2015–16 Zika virus epidemic. Flag icons denote the first announcements of confirmed cases by the respective nation-states, their first deaths, and relevant sessions and announcements of the World Health Organization (WHO), and the U.S. Centers for Disease Control (CDC), as well as relevant virological, epidemiological, and entomological studies.
Christl Ann Donnelly is a professor of statistical epidemiology at Imperial College London, the University of Oxford and a Fellow of St Peter's College, Oxford. She serves as associate director of the MRC Centre for Global Infectious Disease Analysis. In 2022, Donnelly was appointed Head of the Department of Statistics, University of Oxford.
John Brownstein is a Canadian epidemiologist and Professor of Medicine at the Harvard Medical School as well as the Chief Innovation Officer at Boston Children’s Hospital. His research focuses on development of computational methods in epidemiology for applications to public health also known as computational epidemiology or e-epidemiology He is also the founder of several global public health surveillance systems including HealthMap. He is most known for his work on global tracking of disease outbreaks.
John Payne Woodall (1935–2016), known as Jack Woodall, was an American-British entomologist and virologist who made significant contributions to the study of arboviruses in South America, the Caribbean and Africa. He did research on the causative agents of dengue fever, Crimean–Congo hemorrhagic fever, o'nyong'nyong fever, yellow fever, Zika fever, and others.
Jean-Paul Joseph Gonzalez is a French virologist. He graduated from the Medical School of Bordeaux University France.
Jean-Jacques Muyembe is a Congolese microbiologist. He is the general director of the Democratic Republic of the Congo Institut National pour la Recherche Biomedicale (INRB). He was part of team at the Yambuku Catholic Mission Hospital that investigated the first Ebola outbreak, and was part of the effort that discovered Ebola as a new disease, although his exact role is still subject to controversy. In 2016, he led the research that designed, along with other researchers at the INRB and the National Institute of Health Vaccine Research Center in the US, one of the most promising treatment for Ebola, mAb114. The treatment was successfully tested during recent outbreaks in the DRC, on the express decision of the then DRC Minister of Health, Dr Oly Ilunga, despite advice against this from the World Health Organization.
Sir Christopher John MacRae Whitty is a British epidemiologist, serving as Chief Medical Officer for England and Chief Medical Adviser to the UK Government since 2019.
This is a bibliography of the Ebola virus disease, also known as Ebola hemorrhagic fever, a viral hemorrhagic fever of humans and other primates caused by ebolaviruses.
Neil Morris Ferguson is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals. He is the director of the Jameel Institute, and of the MRC Centre for Global Infectious Disease Analysis, and head of the Department of Infectious Disease Epidemiology in the School of Public Health and Vice-Dean for Academic Development in the Faculty of Medicine, all at Imperial College London.
Christophe Fraser is a professor of Infectious Disease Epidemiology in the Big Data Institute, part of the Nuffield Department of Medicine at the University of Oxford.
Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19.
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
